Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chemische Werke Albert, often referred to as Albert Chem Werke, was a prominent German chemical and pharmaceutical manufacturer based in Wiesbaden-Biebrich. Founded in 1858 by Heinrich Albert, the company initially focused on phosphate fertilizers before diversifying into synthetic resins and pharmaceuticals. It is historically significant for developing some of the first synthetic resins and a variety of pharmaceutical products, including analgesics and anti-inflammatories. The company's innovations in polymer chemistry led to the development of early plastics and coating materials. In 1964, the company was acquired by Hoechst AG, and its operations were eventually fully integrated into the Hoechst group, which is now part of Sanofi.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Albert Chem Werke.